Concepedia

Publication | Open Access

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

20

Citations

22

References

2020

Year

Abstract

ClinicalTrials.gov, NCT02959177 (registered November 7, 2016).

References

YearCitations

Page 1